Mr. Norman E Pahmeier, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 Professional Lane, Suite A, Enterprise, AL 36330 Phone: 334-347-4018 Fax: 334-347-0499 |
News Archive
Replacing consumption of sugar-sweetened beverages (SSBs) with water could eliminate an average of 235 excess calories per day among children and adolescents, according to a study published in the April 2009 Archives of Pediatrics & Adolescent Medicine.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that it has been named to the NASDAQ Global Select Market, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market is designated for public companies that meet the highest listing standards in the world, with measures including market value, liquidity and earnings.
Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.
Researchers at Umea University have developed a model for evidence-based predictions of the mosquito-borne dengue virus. Results show that global travel and climate change increase the risk for epidemics of dengue, and potentially other climate-sensitive infectious diseases carried by mosquitos, spreading into temperate areas. This according to a doctoral dissertation at UmeƄ University.
› Verified 4 days ago